Next, an independent analysis of 235 high-risk prostate cancer tissues demonstrated that neither PCGEM1 nor PRNCR1 is associated with aggressive prostate cancer, and neither lncRNA stratifies prostate cancer-specific mortality (Fig. 1C,D and Supplementary Tables 2,3). This evidence concerns the gene PRNCR1 and prostate carcinoma.